Stem Cell Transplantation for Frailty.
作者信息
Le Couteur David G, Anderson Rozalyn M, Newman Anne B, de Cabo Rafael
机构信息
Centre for Education and Research on Aging, Charles Perkins Centre and ANZAC Research Institute, University of Sydney and Concord Hospital, New South Wales, Australia.
Department of Medicine, University of Wisconsin-Madison GRECC, William S Middleton Memorial Veterans Hospital.
出版信息
J Gerontol A Biol Sci Med Sci. 2017 Oct 12;72(11):1503-1504. doi: 10.1093/gerona/glx158.
Abstract
摘要
相似文献
1
Stem Cell Transplantation for Frailty.
J Gerontol A Biol Sci Med Sci. 2017 Oct 12;72(11):1503-1504. doi: 10.1093/gerona/glx158.
2
Application of mesenchymal stem cell therapy for aging frailty: from mechanisms to therapeutics.
Theranostics. 2021 Mar 31;11(12):5675-5685. doi: 10.7150/thno.46436. eCollection 2021.
3
Meeting report: Adult Mesenchymal Stem Cells in Regenerative Medicine conference, August 2007.
Stem Cells. 2007 Nov;25(11):2973-4. doi: 10.1634/stemcells.2007-0769. Epub 2007 Sep 20.
4
Practice of postponing human aging.
Rejuvenation Res. 2010 Apr-Jun;13(2-3):356-8. doi: 10.1089/rej.2009.0952.
5
Mesenchymal Stem Cells as a Biological Drug for Heart Disease: Where Are We With Cardiac Cell-Based Therapy?
Circ Res. 2015 Jul 17;117(3):229-33. doi: 10.1161/CIRCRESAHA.117.306306.
6
Use of dental stem cells in regenerative dentistry: a possible alternative.
Transl Res. 2011 Dec;158(6):385-6. doi: 10.1016/j.trsl.2011.07.008. Epub 2011 Aug 24.
7
Frailty and Rejuvenation with Stem Cells: Therapeutic Opportunities and Clinical Challenges.
Rejuvenation Res. 2019 Dec;22(6):484-497. doi: 10.1089/rej.2017.2048. Epub 2019 Mar 21.
8
Ageing: Develop models of frailty.
Nature. 2014 Aug 21;512(7514):253. doi: 10.1038/512253d.
9
The rejuvenation of aged stem cells for cardiac repair.
Can J Cardiol. 2014 Nov;30(11):1299-306. doi: 10.1016/j.cjca.2014.03.021. Epub 2014 Mar 20.
10
Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty.
Oncotarget. 2016 Mar 15;7(11):11899-912. doi: 10.18632/oncotarget.7727.
引用本文的文献
1
Current Clinical Implications of Frailty and Sarcopenia in Vascular Surgery: A Comprehensive Review of the Literature and Consideration of Perioperative Management.
Ann Vasc Dis. 2022 Sep 25;15(3):165-174. doi: 10.3400/avd.ra.22-00035.
2
Does diet influence aging? Evidence from animal studies.
J Intern Med. 2024 Apr;295(4):400-415. doi: 10.1111/joim.13530. Epub 2022 Jun 24.
3
Mesenchymal Stem Cell Transplantation for the Treatment of Age-Related Musculoskeletal Frailty.
Int J Mol Sci. 2021 Sep 29;22(19):10542. doi: 10.3390/ijms221910542.
4
Increasing cytosolic Ca levels restore cell proliferation and stem cell potency in aged MSCs.
Stem Cell Res. 2021 Oct;56:102560. doi: 10.1016/j.scr.2021.102560. Epub 2021 Oct 3.
5
Inflammation, a common mechanism in frailty and COVID-19, and stem cells as a therapeutic approach.
Stem Cells Transl Med. 2021 Nov;10(11):1482-1490. doi: 10.1002/sctm.21-0074. Epub 2021 Aug 3.
6
Senescence-Associated Secretory Phenotype Suppression Mediated by Small-Sized Mesenchymal Stem Cells Delays Cellular Senescence through TLR2 and TLR5 Signaling.
Cells. 2021 Jan 3;10(1):63. doi: 10.3390/cells10010063.
7
Frailty and Rejuvenation with Stem Cells: Therapeutic Opportunities and Clinical Challenges.
Rejuvenation Res. 2019 Dec;22(6):484-497. doi: 10.1089/rej.2017.2048. Epub 2019 Mar 21.
8
Journal of Gerontology: Biological Sciences. A Long Tradition in Advancing Aging Biology and Translational Gerontology.
J Gerontol A Biol Sci Med Sci. 2018 Mar 2;73(3):271-272. doi: 10.1093/gerona/gly004.
本文引用的文献
1
Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
J Gerontol A Biol Sci Med Sci. 2017 Oct 12;72(11):1513-1522. doi: 10.1093/gerona/glx137.
2
Vascular aging: Molecular mechanisms and potential treatments for vascular rejuvenation.
Ageing Res Rev. 2017 Aug;37:94-116. doi: 10.1016/j.arr.2017.05.006. Epub 2017 Jun 1.
3
A Comparison of Two Mouse Frailty Assessment Tools.
J Gerontol A Biol Sci Med Sci. 2017 Jul 1;72(7):904-909. doi: 10.1093/gerona/glx009.
4
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.
J Gerontol A Biol Sci Med Sci. 2017 Oct 12;72(11):1505-1512. doi: 10.1093/gerona/glx056.
5
Rejuvenating Strategies for Stem Cell-Based Therapies in Aging.
Cell Stem Cell. 2017 Feb 2;20(2):161-175. doi: 10.1016/j.stem.2017.01.008.
6
In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.
Cell. 2016 Dec 15;167(7):1719-1733.e12. doi: 10.1016/j.cell.2016.11.052.
7
Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty.
Oncotarget. 2016 Mar 15;7(11):11899-912. doi: 10.18632/oncotarget.7727.
8
Association Between Circulating Osteogenic Progenitor Cells and Disability and Frailty in Older Persons: The Nepean Osteoporosis and Frailty Study.
J Gerontol A Biol Sci Med Sci. 2016 Sep;71(9):1124-30. doi: 10.1093/gerona/glv190. Epub 2015 Nov 2.
9
Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis.
Transl Res. 2015 Dec;166(6):554-67. doi: 10.1016/j.trsl.2015.09.004. Epub 2015 Sep 18.
10
Geroscience: linking aging to chronic disease.
Cell. 2014 Nov 6;159(4):709-13. doi: 10.1016/j.cell.2014.10.039.
Zotero 插件